Alto Ingredients, Inc. ( ALTO ) NASDAQ Capital Market

Cena: 1.11 ( -0.27% )

Aktualizacja 06-24 20:26
NASDAQ Capital Market
Branża: Chemicals - Specialty
Statystyki
Dywidendy
Rekomendacje
Wyceny
Wskaźniki
Analiza techniczna

Notowania:

Informacje o spółce:
Sektor: Materiały podstawowe
Branża: Chemicals - Specialty
Zatrudnienie: 460
Giełda: NASDAQ Capital Market
Ilość akcji w obrocie: 94%
Ilość akcji: 76 139 100
Debiut giełdowy: 2005-03-24
WWW: https://www.altoingredients.com
CEO: Mr. Bryon T. McGregor
Adres: 1300 South Second Street
Siedziba: 61554 Pekin
ISIN: US0215131063
Opis firmy:

Alto Ingredients, Inc. produkuje i sprzedaje specjalne alkohole i niezbędne składniki w Stanach Zjednoczonych. Firma działa w trzech segmentach: marketing i dystrybucja, produkcja Pekin i inna produkcja. Oferuje specjalne alkohole stosowane w płukaniu jamy ustnej, kosmetyki, farmaceutyki, środki dezynfekujące rąk, środki dezynfekujące i środki czyszczące na rynki zdrowia, domu i placówki; Spirty neutralne ziarna stosowane w napojach alkoholowych, ekstraktach smakowych i occie, a także zarodek kukurydzy stosowanej w olejkach kukurydzianych i dwutlenku węgla na rynki pokarmowe i napojów; A niezbędne składniki obejmują suszone drożdże, gluten kukurydziany, paszę glutenu kukurydzianego, ziarna gorzelni i płynne paszę do komercyjnego karmienia zwierząt i zastosowań karmy dla zwierząt. Firma zapewnia również etanol klasy paliwowej stosowany jako paliwo transportowe i destylarni olej kukurydziany wykorzystywany jako surowiec biodiesla, a także etanol klasy paliwowej wytwarzany przez strony trzecie. Ponadto oferuje usługi transportowe, magazynowe i dostawcze za pośrednictwem zewnętrznych dostawców usług. Firma sprzedaje etanol zintegrowanym firmom naftowym i marketerom benzyny; Niezbędne produkty zasilające do mleczarni i las paszowych; oraz olej kukurydziany do drobiu i klientów biodiesla. Obsługuje pięć placówek produkcyjnych alkoholu, w tym trzy rośliny w środkowo -zachodnich stanach Illinois; oraz dwa obiekty znajdujące się w zachodnich stanach Oregon i Idaho. Firma była wcześniej znana jako Pacific Ethanol, Inc. i zmieniła swoją nazwę na Alto Incredients, Inc. w styczniu 2021 r. Alto Incredients, Inc. został założony w 2003 roku i ma siedzibę w Pekin w stanie Illinois.

Wskaźniki finansowe
Kapitalizacja (USD) 85 703 322
Aktywa: 417 411 000
Cena: 1.11
Wskaźnik Altman Z-Score: 0.3
Słaby (wysokie ryzyko bankructwa)
Dywidenda: 0
P/E: -1.4
Ilość akcji w obrocie: 94%
Średni wolumen: 400 879
Ilość akcji 77 210 200
Wskaźniki finansowe
Przychody TTM 1 002 536 000
Zobowiązania: 153 486 000
Przedział 52 tyg.: 0.76 - 2.05
Piotroski F-Score: 4
Umiarkowany (średnia jakość finansowa)
EPS: -0.8
P/E branży: 22.6
Beta: 1.981
Raport okresowy: 2025-08-04
WWW: https://www.altoingredients.com
Zarząd
Imie i Nazwisko Stanowisko Wynagrodzenie Rok urodzenia
Mr. Bryon T. McGregor Chief Executive Officer, President & Director 511 502 1964
Ms. Auste M. Graham J.D. Vice President, General Counsel & Corporate Secretary 400 954 1980
Mr. James R. Sneed Vice President & Chief Commercial Officer 383 750 1967
Mr. Robert R. Olander Chief Financial Officer 342 204 0
Mr. Ed Baker Vice President of Human Resources 0 0
Mr. Todd E. Benton Chief Operating Officer 0 0
Wiadomości dla Alto Ingredients, Inc.
Tytuł Treść Źródło Aktualizacja Link
Alto Ingredients, Inc. (ALTO) Q1 2025 Earnings Call Transcript Alto Ingredients, Inc. (NASDAQ:ALTO ) Q1 2025 Earnings Conference Call May 7, 2025 5:00 PM ET Company Participants Kirsten Chapman - Investor Relations, Alliance Advisors IR Bryon McGregor - President & Chief Executive Officer Rob Olander - Chief Financial Officer Conference Call Participants Sameer Joshi - H.C. Wainwright Operator Good day, and welcome to the Alto Ingredients First Quarter 2025 Financial Results Conference Call. seekingalpha.com 2025-05-08 02:50:45 Czytaj oryginał (ang.)
Alto Ingredients (ALTO) Reports Q1 Loss, Tops Revenue Estimates Alto Ingredients (ALTO) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to loss of $0.17 per share a year ago. zacks.com 2025-05-07 23:20:36 Czytaj oryginał (ang.)
Alto Ingredients, Inc. Reports First Quarter 2025 Results - Beverage-grade Liquid CO2 Processor Acquisition and Corporate Reorganization  Deliver Improved Year-over-Year Gross Margin and Adjusted EBITDA - globenewswire.com 2025-05-07 20:05:00 Czytaj oryginał (ang.)
Alto Ingredients, Inc. to Release First Quarter 2025 Financial Results on May 7, 2025 PEKIN, Ill., May 01, 2025 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO) a leading producer and distributor of specialty alcohols, renewable fuels and essential ingredients, announced it will release its first quarter 2025 financial results after the close of market on Wednesday, May 7, 2025. globenewswire.com 2025-05-01 12:30:00 Czytaj oryginał (ang.)
Alto Ingredients, Inc. Directors to Not Stand for Reelection PEKIN, Ill., March 18, 2025 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO), a leading producer and distributor of specialty alcohols, renewable fuels and essential ingredients, today announced that two long-standing directors, Douglas L. Kieta and Michael D. Kandris, have decided they will not stand for reelection to the Alto Ingredients Board of Directors at the company's 2025 Annual Meeting of Stockholders, scheduled for June 25, 2025. globenewswire.com 2025-03-18 10:10:00 Czytaj oryginał (ang.)
Alto Ingredients, Inc. Enters into Letter Agreement with Bradley L. Radoff and Michael Torok PEKIN, Ill., March 18, 2025 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO), a leading producer and distributor of specialty alcohols, renewable fuels and essential ingredients, today announced that it has entered into a letter agreement (the “Letter Agreement”) with Bradley L. Radoff and Michael Torok (collectively with their affiliates, the “Radoff/Torok Group”), under which the Radoff/Torok Group has agreed that during the period commencing on the date of the Letter Agreement until the date that is the earlier to occur of (i) thirty (30) days prior to the deadline for delivery of notice under the Company's Amended and Restated Bylaws for the nomination of director candidates for election to the Board of Directors (the “Board”) at Alto Ingredients, Inc.'s (the “Company”) 2026 Annual Meeting of Stockholders (the “2026 Annual Meeting”) or (ii) one hundred twenty (120) days prior to the first anniversary of the 2025 Annual Meeting of Stockholders of the Company, currently scheduled for June 25, 2025 (the “Standstill Period”), at each annual or special meeting of the stockholders of the Company, the Radoff/Torok Group will cause all shares of the Company's common stock beneficially owned by it in favor of all directors nominated by the Board for election and otherwise in accordance with the recommendations of the Board, and against the election of any director nominee not so recommended by the Board. globenewswire.com 2025-03-18 10:00:00 Czytaj oryginał (ang.)
Alto Ingredients, Inc. (ALTO) Q4 2024 Earnings Call Transcript Alto Ingredients, Inc. (NASDAQ:ALTO ) Q4 2024 Earnings Conference Call March 5, 2025 5:00 PM ET Company Participants Kirsten Chapman - IR, Alliance Advisors IR Bryon McGregor - President and CEO Rob Olander - CFO Conference Call Participants Sameer Joshi - H.C. Wainwright Eric Stine - Craig-Hallum Operator Good evening, and welcome to the Alto Ingredients Fourth Quarter and Year-End 2024 Financial Results Conference Call. seekingalpha.com 2025-03-05 21:13:24 Czytaj oryginał (ang.)
Alto Ingredients, Inc. Reports Fourth Quarter and Year-end 2024 Results - Implemented Cost Savings Expected to Yield Approximately $8 Million Annually - - Integrated Accretive Acquisition of a Beverage-grade Liquid CO 2 Processor - - Considering Asset Sales, a Merger or Other Strategic Transactions - globenewswire.com 2025-03-05 18:05:00 Czytaj oryginał (ang.)
Alto Ingredients, Inc. to Present in the 37th Annual Roth Conference PEKIN, Ill., March 04, 2025 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO), leading producer and distributor of specialty alcohols, renewable fuels and essential ingredients, announced that management plans to participate at the 37th Annual Roth Conference on March 16th-18t h. The conference is being held at The Laguna Cliffs Marriott in Dana Point, CA globenewswire.com 2025-03-04 10:30:00 Czytaj oryginał (ang.)
Alto Ingredients, Inc. to Release Fourth Quarter and Year-end 2024 Financial Results on March 5, 2025 PEKIN, Ill., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO) a leading producer and distributor of specialty alcohols, renewable fuels and essential ingredients, announced it will release its fourth quarter and year-end 2024 financial results after the close of market on Wednesday, March 5, 2025. globenewswire.com 2025-02-26 10:30:00 Czytaj oryginał (ang.)
Alto Ingredients Could Soon Have The Right Recipe For A Rebound Alto Ingredients Could Soon Have The Right Recipe For A Rebound seekingalpha.com 2025-02-25 00:35:54 Czytaj oryginał (ang.)
Alto Neuroscience Announces U.S. Patent Granted Covering ALTO-300 as a Treatment for Patients with Major Depressive Disorder Characterized by an Electroencephalogram Biomarker MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)---- $ANRO #PrecisionPsychiatry--Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO) a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced that the U.S. Patent and Trademark Office has granted U.S. Patent Number 12,226,375, with method claims pertaining to treatment of major depressive disorder (MDD) in patients with inadequate response to an antidepressant. The method includes treatment with ALTO-300. businesswire.com 2025-02-19 10:03:00 Czytaj oryginał (ang.)
Alto Ingredients, Inc. Acquires CO2 Processing Plant Adjacent to Columbia Facility, Bolstering Economics and Increasing Asset Valuation - Secures improved, long-term CO2 sales contract,creating immediate bottom-line accretion and future financial upside - globenewswire.com 2025-01-06 10:30:00 Czytaj oryginał (ang.)
Alto Ingredients, Inc. to Cold Idle Magic Valley Facility at Year End - Plant to Operate as a Terminal - PEKIN, Ill., Nov. 29, 2024 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO), a leading producer and distributor of specialty alcohols, renewable fuels and essential ingredients, has announced that it will cold idle its Magic Valley, Idaho facility on December 31, 2024, yet continue to provide terminal services at the plant. globenewswire.com 2024-11-29 10:30:00 Czytaj oryginał (ang.)
Alto Ingredients: Time To Put The Company On The Auction Block - Hold Three weeks ago, Alto Ingredients reported another set of disappointing quarterly results, which caused the stock price to crater by almost 40%. Despite favorable market conditions, the company missed consensus expectations by a wide margin, very similar to last year. Management blamed the poor performance on decreased ethanol demand and lower carbon prices. seekingalpha.com 2024-11-29 08:32:42 Czytaj oryginał (ang.)
Alto Ingredients Publishes its Annual Sustainability Report PEKIN, Ill., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO), a leading producer and distributor of specialty alcohols, renewable fuels and essential ingredients, published its second Sustainability Report highlighting the company's 2023 sustainability metrics and accomplishments. globenewswire.com 2024-11-07 10:30:00 Czytaj oryginał (ang.)
Alto Ingredients, Inc. (ALTO) Q3 2024 Earnings Call Transcript Alto Ingredients, Inc. (ALTO) Q3 2024 Earnings Call Transcript seekingalpha.com 2024-11-06 22:45:21 Czytaj oryginał (ang.)
Alto Ingredients (ALTO) Reports Q3 Loss, Misses Revenue Estimates Alto Ingredients (ALTO) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of $0.02. This compares to loss of $0.05 per share a year ago. zacks.com 2024-11-06 21:51:12 Czytaj oryginał (ang.)
Alto Ingredients, Inc. Reports Third Quarter 2024 Results - Enters CO 2 Transportation and Sequestration Agreement with Vault 44.01 - globenewswire.com 2024-11-06 18:07:00 Czytaj oryginał (ang.)
Alto Ingredients, Inc. Enters CO2 Transportation and Sequestration Agreement with Vault 44.01 PEKIN, Ill., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO), a leading producer and distributor of specialty alcohols, renewable fuels and essential ingredients, announced it entered into a CO2 Transportation and Sequestration Agreement (TSA) with Vault 44.01 to provide transportation, injection and sequestration into the Mt. Simon sandstone formation in Illinois of CO2 produced at Alto Ingredients' Pekin campus. globenewswire.com 2024-11-06 18:05:00 Czytaj oryginał (ang.)
Alto Ingredients, Inc. to Release Third Quarter 2024 Financial Results on November 6, 2024 PEKIN, Ill., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO), a leading producer and distributor of specialty alcohols, renewable fuels and essential ingredients, announced it will release its third quarter 2024 financial results after the close of market on Wednesday, November 6, 2024. globenewswire.com 2024-10-30 18:05:00 Czytaj oryginał (ang.)
Alto Neuroscience Reports Topline Results from a Phase 2b Trial Evaluating ALTO-100 as a Treatment for Major Depressive Disorder MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO), a clinical stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced that the Phase 2b study of ALTO-100 in patients with major depressive disorder (MDD) did not meet its primary endpoint, assessed by a change from baseline in Montgomery-Åsberg Depression Rating Scale (MADRS), compared to placebo. The favorable safety and tolerabili. businesswire.com 2024-10-22 20:30:00 Czytaj oryginał (ang.)
Alto's Magic Valley Facility Production Rate Consistently Achieving Full Capacity PEKIN, Ill., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO), a leading producer and distributor of specialty alcohols, renewable fuel and essential ingredients, provided updates on its Magic Valley facility in Idaho where it has installed Harvesting Technology's patented system to capture its high protein and corn oil products. globenewswire.com 2024-10-15 12:30:00 Czytaj oryginał (ang.)
Alto Ingredients (ALTO) Is Attractively Priced Despite Fast-paced Momentum Alto Ingredients (ALTO) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices. zacks.com 2024-09-24 13:50:31 Czytaj oryginał (ang.)
Alto Ingredients, Inc. to Present in the 26th Annual H.C. Wainwright Global Investment Conference PEKIN, Ill., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO), a producer and distributor of renewable fuel, essential ingredients and specialty alcohols, announced that management plans to participate at the H.C. Wainwright 26th Annual Global Investment Conference on September 10, 2024 in New York City. globenewswire.com 2024-09-03 12:30:00 Czytaj oryginał (ang.)
Alto Ingredients, Inc. (ALTO) Q2 2024 Earnings Call Transcript Alto Ingredients, Inc. (NASDAQ:ALTO ) Q2 2024 Earnings Conference Call August 6, 2024 5:00 PM ET Company Participants Kirsten Chapman - LHA Investor Relations Bryon McGregor - President and Chief Executive Officer Rob Olander - Chief Financial Officer Conference Call Participants Sameer Joshi - H.C. Wainwright Eric Stine - Craig-Hallum Capital Group Justin Dopierala - DOMO Capital Management, LLC Operator Good afternoon, and welcome to the Alto Ingredients Inc. Second Quarter 2024 Financial Results Conference Call. seekingalpha.com 2024-08-09 17:44:07 Czytaj oryginał (ang.)
PALO ALTO NETWORKS ALERT: Bragar Eagel & Squire, P.C. is Investigating Palo Alto Networks on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm NEW YORK, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Palo Alto Networks (NASDAQ: PANW) on behalf of long-term stockholders following a class action complaint that was filed against Palo Alto Networks on February 26, 2024 with a Class Period from August 18, 2023 to February 20, 2024. Our investigation concerns whether the board of directors of Palo Alto Networks have breached their fiduciary duties to the company. globenewswire.com 2024-08-09 01:00:00 Czytaj oryginał (ang.)
Alto Ingredients (ALTO) Reports Q2 Loss, Tops Revenue Estimates Alto Ingredients (ALTO) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to earnings of $0.10 per share a year ago. zacks.com 2024-08-07 00:15:34 Czytaj oryginał (ang.)
Alto Ingredients, Inc. Reports Second Quarter 2024 Results PEKIN, Ill., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO), a producer and distributor of renewable fuel, essential ingredients and specialty alcohols, reported its financial results for the quarter ended June 30, 2024. globenewswire.com 2024-08-06 20:05:00 Czytaj oryginał (ang.)
Alto Ingredients, Inc. to Release Second Quarter 2024 Financial Results on August 6, 2024 PEKIN, Ill., July 30, 2024 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO), a producer and distributor of renewable fuel and essential ingredients and the largest producer of specialty alcohols in the United States, announced it will release its second quarter 2024 financial results after the close of market on Tuesday, August 6, 2024. globenewswire.com 2024-07-30 12:30:00 Czytaj oryginał (ang.)
Alto Neuroscience Initiates Phase 2 Study of ALTO-101, a Novel PDE4 Inhibitor, in Cognitive Impairment Associated with Schizophrenia LOS ALTOS, Calif.--(BUSINESS WIRE)--Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO) today announced the initiation of a Phase 2 double-blind, placebo-controlled study of its transdermal formulation of ALTO-101, a novel PDE4 inhibitor in development for the treatment of cognitive impairment associated with schizophrenia (CIAS). Alto expects to report top-line data from the Phase 2 study in the second half of 2025. “We are excited to initiate our sixth Phase 2 study as a company, across our pipelin. businesswire.com 2024-06-20 12:05:00 Czytaj oryginał (ang.)
Alto Ingredients (ALTO) Loses -20.43% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner Alto Ingredients (ALTO) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock. zacks.com 2024-05-30 14:36:07 Czytaj oryginał (ang.)
5 Top Stocks to Gain From a Rebound in Consumer Confidence With things looking up for the economy, consumer outlays are set to improve, helping stocks such as PlayAGS (AGS), Hasbro (HAS), Lifetime Brands (LCUT), Royal Caribbean Cruises (RCL) and Alto Ingredients (ALTO). zacks.com 2024-05-29 13:11:08 Czytaj oryginał (ang.)